“…For antipsychotic drugs (APs), the amount of data is less impressive, and the amount of safety data available has been lagging the transition from usage patterns from first‐generation antipsychotics (FGAPs) to second‐generation antipsychotics (SGAPs) . During the last 5 years, a substantial amount of safety data has emerged for the SGAP olanzapine and quetiapine especially , while data for other SGAP remain relatively scarce . Antiepileptic drugs (AEDs), used as mood stabilizers within psychiatry, are poorly evaluated for safety during pregnancy except for lamotrigine, which is considered safe, and valproate, which poses a significant risk of major congenital malformations .…”